Dermatologic Toxicity Occurring During Anti-Egfr Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review
Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2017.12.004
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2018
Authors
Publisher
Elsevier BV